1gq0: Difference between revisions

From Proteopedia
Jump to navigation Jump to search
No edit summary
No edit summary
 
(5 intermediate revisions by the same user not shown)
Line 1: Line 1:
==Solution structure of Antiamoebin I, a membrane channel-forming polypeptide; NMR, 20 structures==
==Solution structure of Antiamoebin I, a membrane channel-forming polypeptide; NMR, 20 structures==
<StructureSection load='1gq0' size='340' side='right' caption='[[1gq0]], [[NMR_Ensembles_of_Models | 20 NMR models]]' scene=''>
<StructureSection load='1gq0' size='340' side='right'caption='[[1gq0]]' scene=''>
== Structural highlights ==
== Structural highlights ==
<table><tr><td colspan='2'>[[1gq0]] is a 1 chain structure with sequence from [http://en.wikipedia.org/wiki/Emericellopsis_sp._2723 Emericellopsis sp. 2723]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GQ0 OCA]. <br>
<table><tr><td colspan='2'>[[1gq0]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Emericellopsis_sp._2723 Emericellopsis sp. 2723]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=1GQ0 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=1GQ0 FirstGlance]. <br>
</td></tr><tr><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=AIB:ALPHA-AMINOISOBUTYRIC+ACID'>AIB</scene>, <scene name='pdbligand=DIV:D-ISOVALINE'>DIV</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>, <scene name='pdbligand=PHL:L-PHENYLALANINOL'>PHL</scene></td></tr>
</td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ACE:ACETYL+GROUP'>ACE</scene>, <scene name='pdbligand=AIB:ALPHA-AMINOISOBUTYRIC+ACID'>AIB</scene>, <scene name='pdbligand=DIV:D-ISOVALINE'>DIV</scene>, <scene name='pdbligand=HYP:4-HYDROXYPROLINE'>HYP</scene>, <scene name='pdbligand=PHL:L-PHENYLALANINOL'>PHL</scene>, <scene name='pdbligand=PRD_000161:Antiamoebin+1'>PRD_000161</scene></td></tr>
<tr><td class="sblockLbl"><b>[[Related_structure|Related:]]</b></td><td class="sblockDat">[[1joh|1joh]], [[1ee7|1ee7]], [[1amt|1amt]], [[1m24|1m24]], [[1ob4|1ob4]], [[1ob6|1ob6]], [[1ob7|1ob7]], [[1r9u|1r9u]], [[1ih9|1ih9]], [[1dlz|1dlz]]</td></tr>
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=1gq0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1gq0 OCA], [https://pdbe.org/1gq0 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=1gq0 RCSB], [https://www.ebi.ac.uk/pdbsum/1gq0 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=1gq0 ProSAT]</span></td></tr>
<tr><td class="sblockLbl"><b>Activity:</b></td><td class="sblockDat"><span class='plainlinks'>[http://en.wikipedia.org/wiki/Glucokinase Glucokinase], with EC number [http://www.brenda-enzymes.info/php/result_flat.php4?ecno=2.7.1.2 2.7.1.2] </span></td></tr>
</table>
<tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=1gq0 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=1gq0 OCA], [http://www.rcsb.org/pdb/explore.do?structureId=1gq0 RCSB], [http://www.ebi.ac.uk/pdbsum/1gq0 PDBsum]</span></td></tr>
<table>
<div style="background-color:#fffaf0;">
<div style="background-color:#fffaf0;">
== Publication Abstract from PubMed ==
== Publication Abstract from PubMed ==
Line 14: Line 13:
Solution NMR studies of antiamoebin, a membrane channel-forming polypeptide.,Galbraith TP, Harris R, Driscoll PC, Wallace BA Biophys J. 2003 Jan;84(1):185-94. PMID:12524274<ref>PMID:12524274</ref>
Solution NMR studies of antiamoebin, a membrane channel-forming polypeptide.,Galbraith TP, Harris R, Driscoll PC, Wallace BA Biophys J. 2003 Jan;84(1):185-94. PMID:12524274<ref>PMID:12524274</ref>


From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
From MEDLINE&reg;/PubMed&reg;, a database of the U.S. National Library of Medicine.<br>
</div>
</div>
<div class="pdbe-citations 1gq0" style="background-color:#fffaf0;"></div>
== References ==
== References ==
<references/>
<references/>
Line 21: Line 21:
</StructureSection>
</StructureSection>
[[Category: Emericellopsis sp. 2723]]
[[Category: Emericellopsis sp. 2723]]
[[Category: Driscoll, P C.]]
[[Category: Large Structures]]
[[Category: Galbraith, T P.]]
[[Category: Driscoll PC]]
[[Category: Harris, R.]]
[[Category: Galbraith TP]]
[[Category: Wallace, B A.]]
[[Category: Harris R]]
[[Category: Antiamoebin i]]
[[Category: Wallace BA]]
[[Category: Antibacterial]]
[[Category: Antibiotic]]
[[Category: Antifungal]]
[[Category: Peptaibol]]

Latest revision as of 10:55, 3 May 2023

Solution structure of Antiamoebin I, a membrane channel-forming polypeptide; NMR, 20 structuresSolution structure of Antiamoebin I, a membrane channel-forming polypeptide; NMR, 20 structures

Structural highlights

1gq0 is a 1 chain structure with sequence from Emericellopsis sp. 2723. Full experimental information is available from OCA. For a guided tour on the structure components use FirstGlance.
Ligands:, , , , ,
Resources:FirstGlance, OCA, PDBe, RCSB, PDBsum, ProSAT

Publication Abstract from PubMed

Antiamoebin I is a membrane-active peptaibol produced by fungi of the species Emericellopsis which is capable of forming ion channels in membranes. Previous structure determinations by x-ray crystallography have shown the molecule is mostly helical, with a deep bend in the center of the polypeptide, and that the backbone structure is independent of the solvent used for crystallization. In this study, the solution structure of antiamoebin was determined by NMR spectroscopy in methanol, a solvent from which one of the crystal structures was determined. The ensemble of structures produced exhibit a right-handed helical C terminus and a left-handed helical conformation toward the N-terminus, in contrast to the completely right-handed helices found in the crystal structures. The NMR results also suggest that a "hinge" region exists, which gives flexibility to the polypeptide in the central region, and which could have functional implications for the membrane insertion process. A model for the membrane insertion and assembly process is proposed based on the antiamoebin solution and crystal structures, and is contrasted with the assembly and insertion mechanism proposed for other ion channel-forming polypeptides.

Solution NMR studies of antiamoebin, a membrane channel-forming polypeptide.,Galbraith TP, Harris R, Driscoll PC, Wallace BA Biophys J. 2003 Jan;84(1):185-94. PMID:12524274[1]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

References

  1. Galbraith TP, Harris R, Driscoll PC, Wallace BA. Solution NMR studies of antiamoebin, a membrane channel-forming polypeptide. Biophys J. 2003 Jan;84(1):185-94. PMID:12524274
Drag the structure with the mouse to rotate

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA